Liu S, An L, Yin Z, Lin Y, Ling Z, Deng B, Yu X, Zheng Q, Zhao D, Wu T, Chang AH, Tong C. Five-year outcomes of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation. haematol [Internet]. 2020Sep.10 [cited 2025Jan.6];. Available from: https://haematologica.org/article/view/11872